BiotechTube
Home/Metavention/Pete McNerney
PM

Pete McNerney

Independent Director

Metavention

Therapeutic Areas

CardiovascularMetabolic

Metavention Pipeline

DrugIndicationPhase
Hepatic Denervation for Type 2 DiabetesType 2 DiabetesFeasibility
Renal & Hepatic Denervation for HypertensionHypertensionFeasibility
MODUS Multi-Organ Denervation StudyType 2 Diabetes and HypertensionFeasibility

Leadership Team at Metavention

TB
Todd Berg
Independent Director
TM
Timothy Mills, Ph.D.
Managing Director, Sanderling Ventures (Board Member)
View full Metavention profile